Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread
Moderna's mRNA vaccine Intismeran shows promise, reducing melanoma recurrence and spread in late-stage trials.
Read the full story at Al Jazeera →RiyadhCargo.com is a news monitoring service — the full article is published by Al Jazeera and opens in a new tab.